Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
GlobeNewswire (May 13, 2013)
-
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 30, 2013)
-
GlobeNewswire (Apr 5, 2013)
-
-
PR Newswire (Apr 2, 2013)
-
-
GlobeNewswire (Mar 14, 2013)
-
-
GlobeNewswire (Feb 27, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
5 Low-Debt Biotech Stocks Forecasted For GrowthZetaKap • Sat, Sep 22, 2012 -
-
-
-
-
7 Fast Growing Small Cap Biotech Stocks With Analyst ConfidenceZetaKap • Fri, Jul 6, 2012
-
2012 Biotech IPOs: Age Of The Dreamers?Bioassociate Consulting • Wed, Jul 4, 2012 -
-
-
A Review Of Last Week's IPOs - Part IThe Value Investor • Wed, Apr 4, 2012 -
-
10 U.S. IPOs Planned For This WeekRenaissance Capital IPO Research • Mon, Mar 26, 2012
-
-
-
GlobeNewswire (May 13, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 30, 2013)
-
GlobeNewswire (Apr 5, 2013)
-
PR Newswire (Apr 2, 2013)
-
GlobeNewswire (Mar 14, 2013)
-
GlobeNewswire (Feb 27, 2013)
-
GlobeNewswire (Feb 25, 2013)
-
GlobeNewswire (Feb 7, 2013)
-
GlobeNewswire (Dec 12, 2012)
-
GlobeNewswire (Dec 5, 2012)
MACK vs. ETF Alternatives
Company Description
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States. The company uses its proprietary Network Biology discovery platform to... More
